1. The goal of this clinical trial is to evaluate the efficacy and safety of hyperbaric oxygen (HBO)in stroke patients after endovascular treatment 2. The main questions it aims to answer is:
Whether HBO can improve the prognosis of ischemic stroke patients after endovascular treatment? 3. Participants will:
receive HBO (1.6 Atmosphere Absolute，1.6ATA)，Once a day, for 1 hour each time, for 5 days a week (it can be non-consecutive days), the total course of treatment is 10 times.
undergo three scheduled face to face or telephone follow-up assessments during the 12-month period following HBO.
35-75 years
The symptoms and signs are consistent with acute anterior circulation ischemic stroke. The immediate postoperative angiographic recanalization grade was ≥ 2b.
Neurological deficit score at the time of enrollment: 5 ≤ NIHSS ≤ 15 points
Consciousness status (NIHSS 1a-1b items): 0-1 point
Subjects with HBO contraindications or intolerance
Postprocedural imaging identified either procedure-related subarachnoid hemorrhage or hemorrhagic transformation
Based on the medical history, it is suspected that the cerebral embolism is caused by sepsis or infective endocarditis
Expected lifespan < 90 days